Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
134,553,130
-
Total 13F shares
-
15,867,223
-
Share change
-
-1,885,873
-
Total reported value
-
$47,289,209
-
Price per share
-
$2.98
-
Number of holders
-
56
-
Value change
-
-$7,210,519
-
Number of buys
-
27
-
Number of sells
-
32
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q1 2020
As of 31 Mar 2020,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,867,223 shares.
The largest 10 holders included
Consonance Capital Management LP, FMR LLC, VANGUARD GROUP INC, BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, CHI Advisors LLC, AXA, BlackRock Inc., WELLS FARGO & COMPANY/MN, and MILLENNIUM MANAGEMENT LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.